Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes.
Silva M, Nguyen TH, Philbrook P, Chu M, Sears O, Hatfield S, Abbott RK, Kelsoe G, Sitkovsky MV.
Cell Rep. 2017 Dec 26;21(13):3672-3680. doi: 10.1016/j.celrep.2017.12.014.
Similar articles
Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells.
Sethumadhavan S, Silva M, Philbrook P, Nguyen T, Hatfield SM, Ohta A, Sitkovsky MV.
PLoS One. 2017 Nov 20;12(11):e0187314. doi: 10.1371/journal.pone.0187314. eCollection 2017.
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Ravi D, Beheshti A, Abermil N, Passero F, Sharma J, Coyle M, Kritharis A, Kandela I, Hlatky L, Sitkovsky MV, Mazar A, Gartenhaus RB, Evens AM.
Cancer Res. 2016 Jun 1;76(11):3319-31. doi: 10.1158/0008-5472.CAN-15-2477. Epub 2016 Mar 17.
Immunological mechanisms of the antitumor effects of supplemental oxygenation.
Hatfield SM, Kjaergaard J, Lukashev D, Schreiber TH, Belikoff B, Abbott R, Sethumadhavan S, Philbrook P, Ko K, Cannici R, Thayer M, Rodig S, Kutok JL, Jackson EK, Karger B, Podack ER, Ohta A, Sitkovsky MV.
Sci Transl Med. 2015 Mar 4;7(277):277ra30. doi: 10.1126/scitranslmed.aaa1260.
Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists.
Sitkovsky MV, Hatfield S, Abbott R, Belikoff B, Lukashev D, Ohta A.
Cancer Immunol Res. 2014 Jul;2(7):598-605. doi: 10.1158/2326-6066.CIR-14-0075. Review.
Purinergic signaling during inflammation.
Eltzschig HK, Sitkovsky MV, Robson SC.
N Engl J Med. 2013 Mar 28;368(13):1260. doi: 10.1056/NEJMc1300259. No abstract available.
N Engl J Med. 2012 Dec 13;367(24):2322-33. doi: 10.1056/NEJMra1205750. Review. No abstract available.
Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.
Georgiev P, Belikoff BG, Hatfield S, Ohta A, Sitkovsky MV, Lukashev D.
Eur J Immunol. 2013 Mar;43(3):655-66. doi: 10.1002/eji.201242765. Epub 2013 Jan 31.
In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.
Choukèr A, Ohta A, Martignoni A, Lukashev D, Zacharia LC, Jackson EK, Schnermann J, Ward JM, Kaufmann I, Klaunberg B, Sitkovsky MV, Thiel M.
Transplantation. 2012 Nov 15;94(9):894-902. doi: 10.1097/TP.0b013e31826a9a46.
Adenosine A2A receptor is involved in cell surface expression of A2B receptor.
Moriyama K, Sitkovsky MV.
J Biol Chem. 2010 Dec 10;285(50):39271-88. doi: 10.1074/jbc.M109.098293. Epub 2010 Oct 6.
Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha.
Paone A, Galli R, Gabellini C, Lukashev D, Starace D, Gorlach A, De Cesaris P, Ziparo E, Del Bufalo D, Sitkovsky MV, Filippini A, Riccioli A.
Neoplasia. 2010 Jul;12(7):539-49.
Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow.
Kojima H, Kobayashi A, Sakurai D, Kanno Y, Hase H, Takahashi R, Totsuka Y, Semenza GL, Sitkovsky MV, Kobata T.
J Immunol. 2010 Jan 1;184(1):154-63. doi: 10.4049/jimmunol.0800167. Epub 2009 Nov 30.
Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.
Ramanathan M, Luo W, Csóka B, Haskó G, Lukashev D, Sitkovsky MV, Leibovich SJ.
J Leukoc Biol. 2009 Sep;86(3):681-9. doi: 10.1189/jlb.0109021. Epub 2009 May 28.
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response.
Sitkovsky MV.
Trends Immunol. 2009 Mar;30(3):102-8. doi: 10.1016/j.it.2008.12.002. Epub 2009 Feb 7.
Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.
Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A.
Clin Cancer Res. 2008 Oct 1;14(19):5947-52. doi: 10.1158/1078-0432.CCR-08-0229. Review.
Damage control by hypoxia-inhibited AK.
Blood. 2008 Jun 15;111(12):5424-5. doi: 10.1182/blood-2008-03-143990. No abstract available.
Comparison of Fenestra VC Contrast-enhanced computed tomography imaging with gadopentetate dimeglumine and ferucarbotran magnetic resonance imaging for the in vivo evaluation of murine liver damage after ischemia and reperfusion.
Choukèr A, Lizak M, Schimel D, Helmberger T, Ward JM, Despres D, Kaufmann I, Bruns C, Löhe F, Ohta A, Sitkovsky MV, Klaunberg B, Thiel M.
Invest Radiol. 2008 Feb;43(2):77-91. doi: 10.1097/RLI.0b013e318155aa2e.
Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.
Choukèr A, Thiel M, Lukashev D, Ward JM, Kaufmann I, Apasov S, Sitkovsky MV, Ohta A.
Mol Med. 2008 Mar-Apr;14(3-4):116-23.
Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival.
Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, Ohta A, Lentsch AB, Lukashev D, Sitkovsky MV.
PLoS One. 2007 Sep 5;2(9):e853.
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?
Sitkovsky MV, Ohta A.
Trends Immunol. 2005 Jun;26(6):299-304.
Filters: Manage Filters